hotspot -WSS

hotspot

author：entertainment 2025-09-29 01:46:28 - browse：317

Adam's take main illustration — Molly Ferguson/STAT

This week, a preview of the TUDCA study in ALS and thoughts on how it might impact Amylyx Pharmaceuticals. Also, I chatted with CRISPR Therapeutics CEO Sam Kulkarni about its new investor. Read to the end for some burning questions, random thoughts.

The next ALS data readout — overdue but important

A European academic consortium is expected to announce results soon from a clinical trial investigating the use of a widely available nutritional supplement called tauroursodeoxycholic acid, or TUDCA, in people living with ALS. The outcome of the TUDCA-ALS study could have implications for Amylyx Pharmaceuticals, because TUDCA is one of the two main ingredients in Relyvrio, the company’s approved drug for ALS.

In a recent interview at Amylyx’s Kendall Square headquarters, co-CEOs Justin Klee and Josh Cohen mostly downplayed the suggestion that results from the randomized, placebo-controlled TUDCA study might affect Relyvrio negatively, or even positively.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Wildfire pollution widens asthma inequities on Long Island

WSS

New safety details link Apellis eye drug to rare cases of blindness

Scientists inch closer to single

What the US credit downgrade means for the economy, your finances

Multiple sclerosis has subtypes with different best treatments: study

Republican states more likely to report Covid vaccine side effects

UnitedHealth, in a surprise, takes aim at Steward’s physician group

leisure time

hotspot

The next ALS data readout — overdue but important

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Apple is now the first public company to be valued at $3 trillion

What the airline industry can learn from medicine

Cancer drug shortages should be causing more outrage

Multiple sclerosis has subtypes with different best treatments: study

Virginia high school admissions case could be legal follow

Bird flu reported in person exposed to presumably infected cattle

Medicare details structure of new drug price negotiation program

What the airline industry can learn from medicine

explore

Pancreatic cancer is often deadly, but new discoveries are raising hope

Mitch McConnell episode has important public health takeaway

Covid silver lining: Unprecedented look at human immune system

Medicare Advantage 2025 payments will dip, Biden administration says

U.K. decision on ALS drug has neurologists, advocates up in arms

Multiple sclerosis has subtypes with different best treatments: study

focus

explore

Wikipedia

Wikipedia